NURS 6630 Midterm Exam (Latest 9 Versions ) / NURS 6630N Midterm Exam/ NURS-6630N:Psychopharmacologic Approaches to Treatment of Psychopathology, Walden University

NURS 6630N Midterm Exam
NURS 6630N Week 6 Midterm EXAM
NURS-6630N: Psychopharmacologic
Approaches to Treatment of Psychopathology.


 Latest 9 New Versions
 76 Q & A in Each Version, Verified and 100 % Correct|
 Best document for Exam
 Absolute Satisfaction

, NURS 6630N Midterm Exam
NURS 6630N Week 6 Midterm EXAM
NURS-6630N: Psychopharmacologic Approaches
to Treatment of Psychopathology.


 Latest New Versions
 76 Q & A in Each Version, Verified and 100 % Correct|
 Best document for Exam
 Absolute Satisfaction

, NURS 6630 Midterm Exam

Question1 1 out of 1 points
When an unstable patient asks why it is necessary to add medications to his
current regimen, the PMHNP’s best response would be:

Selected C.
Answer: “Many psychiatric illnesses involve several dys-functioning neurotransmitter systems in
the brain. Often, a single medication may only effect one or two of the dys-functioning
systems. The addition of another medication can work with the current medication in
stabilizing multiple neurotransmitter systems and help to alleviate your symptoms.”
 Question 2
0 out of 1 points
The PMHNP is meeting with a new mother who would like to begin taking
medication again to treat her bipolar depression; she is breastfeeding her 2-
month old daughter. The PMHNP recognizes that which of the following
medications is contraindicated for this patient?

Selected Answer: C.
Lithium (Lithobid)
 Question 3
1 out of 1 points
Mr. Gordon is a middle-aged client who was started on antidepressant
monotherapy for depression. After beginning this medication, the PMHNP
noticed that this client seemed to swing into a hypomanic episode. What can
the PMHNP infer from this behavior change?
Selected Answer: A.
This client may have Bipolar III disorder
 Question 4
1 out of 1 points
A patient presents with frequent episodes of mania. Which statement describes
an appropriate treatment approach for this patient?

Selected Answer: B.
“The patient could benefit from an anticonvulsant.”
 Question 5
1 out of 1 points
The student inquires about antipsychotic medications. Which response by the
PMHNP describes the factors that contribute to reduced risk of extrapyramidal

, symptoms (EPS) for patients who take antipsychotics?

Selected B.
Answer: Those that are potent D2 antagonists with 5HT2A antagonism
properties
 Question 6
1 out of 1 points
After ordering flumazenil (Rumazicon) the PMHNP cautions the staff to monitor for
which possible effect?
Selected Answer: D.
All of the above
 Question 7
1 out of 1 points
The PMHNP is caring for a patient who is taking antipsychotics heard the
psychiatrist tell the patient that the patient would be placed on a different
antipsychotic agent called an atypical antipsychotic. What neurotransmitters
will this new medication work on?
Selected Answer: A.
dopamine and serotonin
 Question 8
1 out of 1 points
While genes have potential to modify behavior, behavior can also modify genes.
How do genes impact this process?

Selected Answer: B.
Changes made to proteins lead to changes in behavior.
 Question 9
1 out of 1 points
Mrs. Schwartzman is a 52-year-old client with schizophrenia and no
established history of depression. When meeting with the PMHNP, she
presents with apathy and withdrawn social behavior, and she reports a loss
of joy from enjoyable activities since starting her new medication. What does
the PMHNP infer from this encounter with the client?
Selected C.
Answer: The new medication is blocking D2 receptors in the mesolimbic
system
 Question 10
1 out of 1 points
A nursing student is seeking clarification on the use of anticonvulsants to treat
depression and is unclear about most effective outcomes. Which of the